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Mechanisms of aging in senescence-accelerated mice <p>Gene-expression analysis and polymorphism screening to study molecular senescence of the retina and hippocampus in two rare  inbred mouse models of accelerated neurological senescence as well as a related and an unrelated normal strain showed that most age- related gene expression changes were strain-specific.</p>
Abstract
Background: Progressive neurological dysfunction is a key aspect of human aging. Because of
underlying differences in the aging of mice and humans, useful mouse models have been difficult to
obtain and study. We have used gene-expression analysis and polymorphism screening to study
molecular senescence of the retina and hippocampus in two rare inbred mouse models of
accelerated neurological senescence (SAMP8 and SAMP10) that closely mimic human neurological
aging, and in a related normal strain (SAMR1) and an unrelated normal strain (C57BL/6J).
Results: The majority of age-related gene expression changes were strain-specific, with only a few
common pathways found for normal and accelerated neurological aging. Polymorphism screening
led to the identification of mutations that could have a direct impact on important disease
processes, including a mutation in a fibroblast growth factor gene, Fgf1, and a mutation in and
ectopic expression of the gene for the chemokine CCL19, which is involved in the inflammatory
response.
Conclusion: We show that combining the study of inbred mouse strains with interesting traits
and gene-expression profiling can lead to the discovery of genes important for complex
phenotypes. Furthermore, full-genome polymorphism detection, sequencing and gene-expression
profiling of inbred mouse strains with interesting phenotypic differences may provide unique
insights into the molecular genetics of late-manifesting complex diseases.
Background
Aging is defined by an increase in the probability of death
over time associated with characteristic changes in phenotype
[1]. Changes in the global control of transcription have been
directly implicated in the aging process in yeast, and
increased histone deacetylation activity (a process involved in
chromatin silencing) results in extended life span in
Caenorhabditis elegans [2-4]. Genomic instability has also
been implicated as a causative agent in cellular senescence in
mammals. This relationship between genomic instability and
aging in mammals is supported by work demonstrating a cor-
relation between senescence and the loss of ribosomal DNA,
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increases in chromosomal abnormalities and telomere short-
ening [1,5-7]. In addition, certain mutations in humans can
accelerate aging-specific events, resulting in progeric diseases
that include Hutchinson-Gilford syndrome, Werner syn-
drome, Cockayne syndrome and xeroderma pigmentosum [8-
10]. Except for Hutchinson-Gilford syndrome, each of these
disorders results from mutations in DNA repair proteins, sug-
gesting that a stochastic build-up of errors in DNA could form
the basis for some common traits of aging. Recent studies
have indicated that Hutchinson-Gilford syndrome is caused
by specific mutations in lamin A, a gene involved in structural
integrity of the nuclear membrane [11,12]. Interestingly, some
genetic disorders that exhibit aspects of accelerated senes-
cence also demonstrate genomic instability, including several
mentioned above as well as ataxia-telangiectasia and Bloom's
syndrome [13-17].
While single-gene progerias can provide insight into age-
related processes, most patients exhibit only a subset of the
phenotypes associated with aging. Thus, the process may be
fundamentally different from normal aging, which involves
multiple events and tissues. To complement studies of single-
gene progerias and other models of mammalian senescence,
we have chosen to study a more complex model of aging: the
senescence-accelerated mouse (SAM) strains. The senes-
cence-accelerated mice are a collection of inbred mouse
strains developed as models of accelerated aging, and include
nine short-lived, senescence-accelerated mouse prone strains
(SAMP) and three longer lived control strains designated
senescence-accelerated mouse resistant (SAMR) [18]. The
SAMP strains exhibit several features that make them inter-
esting models of human aging, including age-associated early
onset of senile amyloidosis, degenerative arthropathy, cata-
racts, osteoporosis and osteoarthritis, reduced fecundity and
early loss of fertility [18-20]. Mapping studies have been lim-
ited to microsatellite haplotype analyses characterizing the
genetic relationships between the SAM strains [21]. In addi-
tion, there is currently no genome sequence available for
these strains, making it difficult to use comparative genomics
to identify genetic differences responsible for their pheno-
typic differences. Furthermore, the strains involved in these
studies require continual trait-based selection to maintain
the phenotype. As standard quantitative trait locus mapping
approaches would be extremely difficult with such strains, we
sought to test the hypothesis that gene-expression profiling
combined with candidate gene sequencing would lead to the
identification of mutations and/or expression changes that
track with the strain-specific phenotypes, thereby allowing us
to identify relevant pathways and generate candidate genes
for future experiments.
Our study focused on the identification of genes involved in
neurological aspects of aging, using two SAMP strains:
SAMP8/Ta (S8) and SAMP10//Ta (S10), and two control
strains: the related SAMR strain SAMR1TA (SR1) and a com-
monly used inbred mouse strain C57BL/6J (B6J). The S8 and
S10 strains exhibit age-related behavioral and neuropatho-
logical phenotypes, in addition to osteoporosis and prema-
ture loss of fertility, that make them particularly useful
models of human neurological aging [22-25]. These pheno-
types include deficits in learning and memory, emotional dis-
orders and abnormal circadian rhythms [18,26]. S8 mice also
develop a severe age-related impairment in acquisition and
retention of the passive avoidance response, as well as a
reduced-anxiety behavior [23,27]. Old S10 mice exhibit
behavioral depression on tail suspension and forced swim-
ming tests [23]. A unique pathological feature of senescence
in S10 mice is an age-related atrophy of the brain [28]. Neu-
ron shrinkage and degeneration in S10 mice result in progres-
sive decrease of mean brain weight beginning at 4 months of
age [28]. In addition to the neurobehavioral and physiologi-
cal phenotypes, S8 mice demonstrate an age-related degener-
ation of the retinal pigment epithelium-Bruch's membrane-
choriocapillaris complex, and a degeneration of receptor cells
and ganglion neurons in the retina suggestive of age-related
macular degeneration in humans [29].
The S8 and S10 strains are also interesting in that although
inbred, trait-based selection is necessary to maintain the phe-
notype of the age-associated disorders over generations [30].
Thus, while the phenotypes are heritable, they are clearly part
of a complex trait that probably involves the interaction of
multiple genes and/or alleles, suggesting that these strains
may better model the processes associated with mammalian
aging than single-gene progeria models.
To explore the events involved in the molecular senescence of
the mammalian brain, we established and aged the colonies,
verified the phenotypes, and performed gene-expression
analysis of the retina and hippocampus in S8 and S10 mice
using oligonucleotide microarrays [31]. As a control, we stud-
ied the SAMR strain SR1. All SAM strains were originally
derived from the AKR/J inbred mouse strain, but SR1 dem-
onstrates a longer life span and lacks the accelerated senes-
cence that is a hallmark of the SAMP strains. Furthermore, we
also analyzed the gene-expression data in the context of an
additional, unrelated inbred mouse strain, B6J, to distinguish
strain-background specific (AKR-specific) from more general
changes of the aging transcriptome. Finally, we took advan-
tage of a focused polymorphism screen to identify two genes
harboring mutations in the SAMP strains that may play
important roles in their accelerated-aging phenotypes.
Results
Verification of phenotype in SAM Strains
As accelerated aging of the senescence-prone mouse strains is
a complex phenotype, we monitored the life span, pathology,
fecundity and learning and memory behavior of all genera-
tions of mice to validate the accelerated-senescence pheno-
type in our facility and employed retrospective pedigree
selection on S8 and S10 mice as previously described [30]http://genomebiology.com/2005/6/6/R48 Genome Biology 2005,     Volume 6, Issue 6, Article R48       Carter et al. R48.3
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(see Additional data file 2). As expected, both S8 and S10
strains had increased mortality and morbidity with age rela-
tive to SR1 and B6 mice (Figure 1a; B6 data from Pugh et al.
[32]). S8 mice had the shortest life span, with a median life
span 39% shorter than that of SR1. S10 mice showed an 18%
decrease in median life span. These data are consistent with
the reported life spans of SAM strains reared under conven-
tional conditions, where the median survival time of all SAMP
strains (including not only S8 and S10 but also other acceler-
ated-senescence strains) is reported to be 40% less than that
of SAMR strains [20]. Whereas the single greatest cause of
death in the SAMR1 strain was cancer (consistent with the
original AKR/J strain from which the SAM strains were
developed), the SAMP10 and SAMP8 mice showed a decrease
in cancer-related deaths and an increase in death due to infec-
tion or a wasting syndrome consistent with neurological dys-
function. Finally, an analysis of litter size also showed a
significant decrease in fecundity in both S8 and S10 mice as
compared with SR, consistent with accelerated aging of the
reproductive organs (data not shown) [33].
Most relevant to the studies performed in our laboratory, a
progressive deterioration in learning and/or memory per-
formance has been reported in S8 and S10 mice [22,23]. To
confirm and elucidate these phenotypes, behavioral analysis
of our colonies was performed using a single-trial passive
avoidance paradigm, in which shorter latency to entering a
darkened chamber indicates a lower retention (memory) of a
previous foot shock. This test was performed on both younger
(average age of 16 weeks) and older (average age of 81 weeks)
mice (Figure 1b). At 16 weeks of age, S8 mice demonstrate an
average latency 52.1 seconds shorter than SR1 and 16 week-
old S10 mice demonstrate an average latency 56.7 seconds
shorter than SR1. These differences between the SAMP
strains and the SAMR strain are significant using a two-tailed
Student's t-test (p < 0.003 for SAMP8 versus SAMR1 and p <
0.002 for SAMP10 versus SAMR1). At 81 weeks of age, the
retention deficits for S8 and S10 mice have worsened, with S8
mice showing a 119% decrease and S10 mice showing a 52%
decrease in performance, while SR1 mice show only a 14%
decrease. Consistent with previously published results, the
SAMP mice exhibit a severe age-related decline in learning
and memory relative to control mice. Therefore, within the
cohort studied for phenotype, RNA profiling, DNA sequenc-
ing and in situ hybridization, the animals showed a consistent
phenotype within the colony.
Neurological gene-expression profile of aging is unique 
among strains
The anatomical and behavioral analyses of the SAM strains
are consistent with age-related deficits in hippocampal-medi-
ated processes that are accelerated in S8 and S10. In addition,
studies of the retina also suggest a retinal degeneration phe-
notype specific to S8 mice that may mimic age-related
declines in retinal function in humans [29]. The hippocampus
and retina of old (16 month-old S8, S10, SR and 21 month-old
B6J) and young (3 month-old) mice were subjected to gene-
expression analysis studies using Affymetrix oligonucleotide
microarrays (see Lipshutz et al. [31], Sandberg et al. [34],
Caceres et al. [35], and Materials and methods for details). As
B6J mice exhibit a longer life-span than SR1 mice, we sacri-
ficed B6J mice at 21 months of age, approximately at the same
95% survival point as seen for 16 month-old SR1 mice (see
Figure 1a). To ensure that the analysis method used mini-
mized false positives and maximized reliability of the results,
the number of independent replicate samples needed was
S8 and S10 mice exhibit accelerated-senescence phenotypes Figure 1
S8 and S10 mice exhibit accelerated-senescence phenotypes. (a) 
Proportion of surviving S8 mice (blue squares, n = 237), S10 mice (purple 
diamonds, n = 169), SR1 mice (green triangles, n = 189) and B6 mice (black 
crosses, n = 75, data from Pugh et al. [32]). Using a Kaplan-Meier survival 
analysis, the S8 and S10 survival profiles are significantly different from SR1 
(p < 0.0001 and p < 0.0015, respectively) by the Mantel-Cox log rank test. 
Arrows and lines indicate the two ages (3 months and 16 months) at 
which mice were dissected and used for the gene expression experiments 
in the SAM strains. An arrow also indicates the age at which the old B6J 
mice were sacrificed for gene expression analysis. (b) Retention of foot 
shock is indicated as latency to entry into the dark chamber (day 2-day 1) 
in a passive avoidance paradigm. Difference in latency to entry is shown on 
the y-axis and age on the x-axis at a young time point and an old time point 
for S8 (blue: young n = 43, old n = 8), S10 (purple: young n = 31, old n = 7) 
and SR1 (green: young n = 41, old n = 27) mice. Error bars indicate 
standard error. S8 and S10 mice show decreased latency to entry relative 
to SR1 at both young (two-tailed Student's t-test: p < 0.003 and p < 0.002, 
respectively) and old (p < 0.05, S8) time points.
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determined by the variation inherent in the samples (see
Additional data file 3). In the case of younger animals, two
independent samples for each time point and tissue were
required. For the 16 month-old S8, S10 and SR hippocampus
samples, three samples were used. For retinal samples, four
retinas from two mice were pooled to obtain sufficient RNA
for each sample. Reproducibility was measured using the
Pearson correlation coefficient based on the signal intensities
of all genes on the array between replicate samples (perfect
correlation = 1.0), and the average correlation coefficients of
the replicates in each condition were as follows: young hip-
pocampus, 0.9914; young retina, 0.9946; old retina, 0.9949;
old B6J hippocampus, 0.9922, and old S8, S10 and SR hip-
pocampus, 0.9695 (see Additional data file 3 for all replicate
correlation coefficients). Representative correlation plots are
shown in Additional data file 5. Whereas most of the repli-
cates demonstrated a high reproducibility (> 0.99 correlation
coefficient), there was greater variability seen in the old S8,
S10 and SR hippocampus replicates (as indicated by lower
correlation coefficients). As a result, in these cases additional
samples were prepared and analyzed. The number of genes
differentially expressed between replicates was used as an
estimation of the false positive rate. In all cases very few genes
were identified as differentially expressed between replicates,
indicating a very low expected false-positive rate in the exper-
imental analyses (Additional data file 3). All data and analysis
tools used in this publication are available at [36].
Several types of analyses were performed. First, we character-
ized gene-expression profiles of aging within each strain.
Pairwise comparisons between each tissue sample for young
and old mice of the same strain were performed. A given
mRNA transcript was considered differentially expressed in a
comparison of any two samples if it met the following criteria:
a Wilcoxon signed rank test (relative) (WSRR) p-value of p ≤
0.01 and increase fraction ≥  0.7; or p ≤  0.0316 and increase
fraction ≥  0.8; or p ≤  0.01 and increase fraction ≤  0.3; or p ≤
0.0316 and increase fraction ≤  0.2. A fold change of 1.5 or
greater and an average difference change in signal of 30 or
more was also required. A gene was considered differentially
expressed between conditions (that is, old S8 retina versus
young S8 retina) only if it met the above criteria in more than
70% of the pairwise comparisons (3/4 or 4/4 comparisons),
and carried a statistically significant absolute call of 'Present'
(P) or 'Marginal' (M) in at least one sample (see Materials and
methods for more detail).
Subsequently, those genes found to be differentially
expressed by the strict criteria described above were exam-
ined in all other strains and were considered differentially
expressed in another strain if the expression change during
aging was significant to an average (WSRR) p-value = 0.05.
Finally, the genes that were differentially expressed during
aging in each strain were clustered into heat-map views based
on their expression patterns, allowing us to examine similar-
ities and differences in transcriptional aging between strains
(Figure 2).
Unexpectedly, each strain showed a remarkably unique pro-
file of aging. In the aging hippocampus, only a single gene out
of a total 115 (complement component 4 (C4)) changed with
age in all four strains (Figure 2a). Seven genes increased in
B6J and at least one SAM strain hippocampus. Finally, two
genes were downregulated with age in all three SAM strains,
but did not change in B6J. The vast majority of changes dur-
ing aging (75/115 or 65%) were unique to one of the four
strains. Interestingly, the genetic background of the animals
played an important part in the similarity of the profiles, as
related SAM strains exhibited patterns of gene-expression
change more similar to one another than they did to B6J, in
spite of the fact that SR1 and B6J both demonstrate a 'normal'
phenotype, lacking the accelerated neurological pathology
seen in S8 and S10 mice.
To determine if these observations extended to other central
nervous system (CNS) tissues, similar analyses of the retina
were performed (Figure 2b). As seen for the hippocampal
data, only a single gene (AI845165, similar to the phosphati-
dylserine decarboxylase gene) changed with age in all SAM
strains and B6J. Also like the hippocampus, the majority (30/
46 or 65%) of gene expression changes in the retina were
unique to a single strain, again indicating that neuronal tis-
sues of different strains can exhibit dramatically different
transcriptional responses to aging.
Strain differences in gene expression
The analysis of the aging retina and hippocampus demon-
strated that interesting and specific transcriptional events
occurred within the hippocampus and retina of each strain
with age. The results suggest that differences in expression
levels of important genes between the senescence-prone and
-resistant strains could play an important role in mediating
the age-related differences observed between these strains.
One hypothesis suggests that differences in expression levels
of important genes between the senescence-prone and -
resistant strains could play an important role in mediating the
age-related differences observed between these strains.
To identify such differences, we compared gene expression
results for the senescence-accelerated S8 and S10 strains to
the closely related, yet disease-free, control SR1 strain at both
young and old time points (Figure 3). Gene-expression differ-
ences were identified using similar analyses to those
described above, but comparing young and old S8 and S10
with SR1 (young 'prone' versus young 'resistant' or old 'prone'
versus old 'resistant') (see Materials and methods and Addi-
tional data file 1 for more analysis methodology). A total of
124 genes were identified as differentially expressed in the
hippocampus between strains in either young or old animals
(Figure 3a). A similar analysis of the retina yielded 118 geneshttp://genomebiology.com/2005/6/6/R48 Genome Biology 2005,     Volume 6, Issue 6, Article R48       Carter et al. R48.5
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Strain-specific aging gene-expression profiles Figure 2
Strain-specific aging gene-expression profiles. (a) Heat-map view of differentially expressed genes between 3- and 16-month-old S8, S10, SR1 and B6J 
hippocampus. Fold change of old relative to young hippocampus is numerically indicated within each box. Bright red (increase in expression level) and 
bright green (decrease in expression level) indicate genes that met the most stringent criteria for an expression-level change, including an average WSRR p 
< 0.01. A gene is colored orange or light green if its expression increased or decreased with an average WSRR p < 0.05. Box 1, genes changed in common 
with three or more strains; box 2, genes changed in only two strains; box 3, genes with changes unique to a single strain; and box 4, genes with 
inconsistent patterns of change. (b) Heat-map view of differentially expressed genes between 3-month-old and 16-month-old S8, S10, SR1 and B6J retinas. 
The analysis was performed as described for the hippocampus.
Probe Set Acc # Symbol Gene S8 S10 SR c57 Probe Set Acc# Symbol Gene S8 S10 SR c57
103033_at X06454 C4 complement component 4 2.2 2.6 3.1 3.7 97448_at AI845165 2310047I15Rik sim. phosphatidylserine decarboxylase 1.6 1.9 2.0 2.1
99897_at U14420 Gabrb3 GABA-A receptor- beta 3 -2.0 -3.0 -3.1 93120_f_at V00746 nd nd 1.8 2.0 1.7
95393_at AI503362 LOC228662 similar to BTB/POZ domain containing protein 3 -1.5 -2.6 -3.1 104518_at AJ239052 Cryba1 crystallin- beta A1 -3.0 -2.1 -4.4
93592_at X82648 Apod apolipoprotein D 1.9 1.9 1.2 97540_f_at M69069 H2-D1 histocompatibility 2- D region locus 1 . 1.7 1.8 1.8
97448_at AI845165 2310047I15Rik similar to phosphatidylserine decarboxylase 1.5 1.8 1.8 101058_at J00356 Amy1 amylase 1- salivary . 1.6 1.8 1.4
102348_at AI551087 LOC226187 hypothetical gene . 1.9 2.1 1.6 96041_at AB016424 Rbm3 RNA binding motif protein 3 1.7 1.6
160417_at U86090 Kif5b kinesin family member 5B . 2.1 2.2 1.9 160894_at X61800 Cebpd CCAAT/enhancer binding protein (C/EBP)- delta 1.9 1.8
102062_at U85614 Smarcc1 SWI/SNF related-matrix ass. actin dep. reg. of chromatin- c1 2.0 2.7 99842_at AB000636 Col19a1 procollagen- type XIX- alpha 1 1.9 1.8
102431_at M18775 Mapt microtubule-associated protein tau 1.6 1.7 97317_at AW122933 Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 . 1.3 1.8
101215_at M86567 Gabra2 GABA-A receptor- alpha 2 -2.3 -2.9 93088_at X01838 B2m beta-2 microglobulin . 3.2 1.6
99528_at AW122015 Spin spindlin -2.6 -2.1 92426_at AI877157 Tm4sf9-pending transmembrane 4 superfamily member 9 -2.2 2.0
97282_at D10049 Mela melanoma antigen- 80 kDa 3.2 8.8 100910_at M14689 Surf3 surfeit 3 -1.9 2.3
160841_at AW047343 Dbp D site albumin promoter binding protein 2.5 4.5 92546_r_at AB006361 Ptgds prostaglandin D2 synthase (21 kDa- brain) -2.0 8.6
101886_f_at X52490 H2-D histocompatibility 2- D region 1.8 2.3 97579_f_at AJ224343 Crygf crystallin, gamma F -8.3 -6.0
96041_at AB016424 Rbm3 RNA binding motif protein 3 1.8 2.0 93328_at X57437 Hdc histidine decarboxylase cluster . 6.3 2.3
94208_at AW045202 P5 protein disulfide isomerase-related protein -1.9 -2.5 93443_at AW212271 1110027O12Rik RIKEN cDNA 1110027O12 gene . 1.6 1.8
92630_r_at D63707 Hdgf hepatoma-derived growth factor -1.7 -1.4 95119_at AA866888 1110038D17Rik RIKEN cDNA 1110038D17 gene -1.5
98967_at U04827 Fabp7 fatty acid binding protein 7, brain -2.1 -2.1 100386_at AF056973 Gnaz guanine nucleotide binding protein, alpha z -1.8
98004_at M63554 Pkia protein kinase inhibitor- alpha -2.1 -2.1 94981_i_at AI852470 Nme3 expressed in non-metastatic cells 3 -1.9
104592_i_at AI595996 Mef2c myocyte enhancer factor 2C . 3.8 2.3 96263_at AW124933 4930524H12Rik RIKEN cDNA 4930524H12 gene -1.9
104206_at AA815845 0610012A05Rik RIKEN cDNA 0610012A05 gene . 3.3 2.6 98329_at X98847 Pfkfb2 6-phosphofructo-2-kinase/fructose-2-6-biphosphatase 2 -2.0
97083_at AA600468 Eif2s2 eukaryotic translation initiation factor 2, subunit 2 . 2.3 3.9 94208_at AW045202 P5 protein disulfide isomerase-related protein -2.0
103787_at Y00305 Kcna1 K+ voltage-gated channel- shaker-related subfamily- 1 . 2.2 2.7 93023_f_at M32459 Hist1h3f histone 1, H3f -2.2
103904_at X81584 Igfbp6 insulin-like growth factor binding protein 6 . 2.0 1.9 94980_at AI006319 2010300F21Rik RIKEN cDNA 2010300F21 gene -2.4
102870_at AW125272 5930418K15Rik RIKEN cDNA 5930418K15 gene . 1.9 1.8 101447_at M88127 Apc adenomatosis polyposis coli -2.5
100514_at M63660 Gna13 guanine nucleotide binding protein- alpha 13 . 1.8 1.8 98805_at U54643 tub tubby -3.0
96961_at AI503821 Zfp144 zinc finger protein 144 . 1.9 1.5 101881_g_at L22545 Col18a1 procollagen- type XVIII- alpha 1 . 4.7
100297_at AA693125 AI447817 expressed sequence AI447817 . 1.9 2.0 102061_at AF100171 Mlf1 myeloid leukemia factor 1 . 3.7
100379_f_at AI837905 nd nd . 1.7 1.6 160413_at U17259 Nsg2 neuron specific gene family member 2 . 2.1
94689_at C79248 C79248 expressed sequence C79248 . 2.4 2.2 103891_i_at AI197161 Ell2 eleven-nineteen lysine-rich leukemia gene 2 . 2.1
160614_at U92437 Pten phosphatase and tensin homolog . 2.1 1.8 97198_at X75926 Abca1 ATP-binding cassette- sub-family A 1 . 2.1
97349_at AA727410 2610019M19Rik RIKEN cDNA 2610019M19 gene . 1.9 2.5 94433_at AW060684 AI316867 expressed sequence AI316867 . 2.1
102224_at AF056187 Igf1r insulin-like growth factor I receptor . 1.8 2.1 94809_at U52945 tsg101 tumor susceptibility gene 101 . 2.1
104407_at L25274 Alcam activated leukocyte cell adhesion molecule . 1.6 2.6 102983_at U58992 Madh1 MAD homolog 1 (Drosophila) . 1.9
93528_s_at AI848050 Klf9 Kruppel-like factor 9 . 1.5 1.6 93573_at V00835 Mt1 metallothionein 1 . 1.9
160954_at AF096867 Syn2 synapsin II . -2.4 -2.2 104761_at AA612450 2310046B19Rik RIKEN cDNA 2310046B19 gene . 1.9
97960_at AW125800 9330200A01 hypothetical protein 9330200A01 . -2.1 -1.8 94057_g_at M21285 Scd1 stearoyl-Coenzyme A desaturase 1 . 1.8
96599_at AI845874 C330016K18Rik RIKEN cDNA C330016K18 gene 3.7 2.6 104155_f_at U19118 Atf3 activating transcription factor 3 . 1.7
97540_f_at M69069 H2-D1 histocompatibility 2- D region locus 1 . 2.5 1.5 96295_at AW122030 D8Ertd814e DNA segment- Chr 8- ERATO Doi 814- expressed . 1.6
101554_at U57524 Nfkbia NFK light chain gene enhancer in B-cells inhibitor, a 2.8 95575_r_at AI641995 AW045841 expressed sequence AW045841 . -1.7
93284_at D78135 Cirbp cold inducible RNA binding protein 2.4 101883_s_at L22977 Xlr3b X-linked lymphocyte-regulated 3b . -2.2
103460_at AI849939 5830413E08Rik RIKEN cDNA 5830413E08 gene 1.8 101869_s_at J00413 Hbb-b1 hemoglobin, beta adult major chain . 2.0
98984_f_at D50430 Gdm1 glycerol phosphate dehydrogenase 1- mitochondrial 1.8 160901_at V00727 c-fos FBJ osteosarcoma oncogene . 2.2
101561_at K02236 Mt2 metallothionein 2 1.8 93264_at AI843895 Srebf1 sterol regulatory element binding factor 1 . 1.6
160547_s_at AI839138 Txnip thioredoxin interacting protein 1.7 94375_at Y11666 Hk2 hexokinase 2 . 1.8
98857_at U29086 Neurod6 neurogenic differentiation 6 -1.6 94781_at V00714 Hba-a1 hemoglobin alpha, adult chain 1 . 2.2
93892_at Y18298 Cugbp2 CUG triplet repeat-RNA binding protein 2 -1.7 95331_at AF076930 Rgr retinal G protein coupled receptor . 3.0
92433_at AF067180 Kif5c kinesin family member 5C -1.7 95620_at AW120882 2310016E22Rik RIKEN cDNA 2310016E22 gene -1.9 2.0
101955_at AJ002387 Hspa5 heat shock 70kD protein 5 -1.8
97760_at M21041 Mtap2 microtubule-associated protein 2 -1.8
99489_at U23921 Osp94 osmotic stress protein 94 kDa -1.8
160934_s_at X05546 nd gag related peptide -1.8
104249_g_at AW227650 0610038P07Rik RIKEN cDNA 0610038P07 gene -1.9
160330_at AW122453 Chordc1 CHORD containing- zinc-binding protein 1 -2.0
99501_at AA882416 4933429H19Rik RIKEN cDNA 4933429H19 gene -2.3
103523_at AI851703 Leng8 leukocyte receptor cluster (LRC) member 8 -3.1
97310_at AW124318 3110002K08Rik RIKEN cDNA 3110002K08 gene -3.2
98805_at U54643 tub tubby -6.5
101308_at M64228 Kcnb1 K+ voltage gated channel- Shab-related subfamily- 1 . 3.1
96513_at AA794350 C75939 expressed sequence C75939 . 2.4
161257_r_at AV321519 AI790646 expressed sequence AI790646 . 1.9
103082_at AI847507 5430429D03Rik RIKEN cDNA 5430429D03 gene . 1.8
160696_at U00689 Tia1 cytotoxic granule-associated RNA binding protein 1 . 1.7
161054_at X92864 Spock1 sparc/osteonectin-cwcv and kazal-like domains proteoglycan 1 . -1.8
101883_s_at L22977 Xlr3b X-linked lymphocyte-regulated 3b . -2.5
100956_at AB005141 Kl klotho . -3.5
102726_at D17584 Tac1 tachykinin 1 . 16.6
94516_f_at M55181 Penk1 preproenkephalin 1 . 12.3
93615_at AF020200 Pbx3 pre B-cell leukemia transcription factor 3 . 4.4
96183_at AW122985 Foxp1 forkhead box P1 . 3.3
93178_at AW050346 Ngef neuronal guanine nucleotide exchange factor . 3.0
92633_at AJ242663 Ctsz cathepsin Z . 2.9
96784_at AW123269 1110037A17Rik RIKEN cDNA 1110037A17 gene . 2.5
93159_at AW122995 R74640 expressed sequence R74640 . 2.3
95955_at AI606577 C76940 expressed sequence C76940 . 2.2
95493_at X66405 Col6a1 procollagen- type VI- alpha 1 . 2.1
98026_g_at M34896 Evi2 ecotropic viral integration site 2 . 2.1
103833_at AF077659 Hipk2 homeodomain interacting protein kinase 2 . 1.9
94420_f_at AB000777 Cry1 cryptochrome 1 (photolyase-like) . 1.9
103288_at AF053062 Nrip1 nuclear receptor interacting protein 1 . 1.8
100964_at AF035208 Vti1b vesicle transport through interaction with t-SNAREs 1b . 1.8
101892_f_at Z67963 Fts fused toes . 1.7
104605_at AW047554 AI115388 EST AI115388 . 1.6
97263_s_at AI846289 Csnk1d casein kinase 1- delta . -1.7
92673_at U58886 Sh3d2a SH3 domain protein 2A . -1.7
102342_at U10120 Nsf N-ethylmaleimide sensitive fusion protein . -1.9
94336_at AI838318 AI850305 expressed sequence AI850305 . -1.9
97228_at AI844417 0610011C19Rik RIKEN cDNA 0610011C19 gene . -1.9
97520_s_at X83569 Nnat neuronatin . -1.9
92426_at AI877157 Tm4sf9-pending transmembrane 4 superfamily member 9 . -2.0
104673_at X65138 Epha4 Eph receptor A4 . -2.1
93188_at AJ243964 Dkk3 dickkopf homolog 3 (Xenopus laevis) . -2.3
102259_at AF058799 Ywhag 3-monooxgenase/tryptophan 5-monooxgenase act. pro.-G . -2.4
100418_at AW123750 Gng2 G protein- gamma 2 . -2.5
97203_at X61399 Mlp MARCKS-like protein . -2.5
92358_at U59230 Nell2 nel-like 2 homolog (chicken) . -2.5
93936_at L09562 Ptprg protein tyrosine phosphatase- receptor type- G . -2.6
93648_at L28035 Prkcc protein kinase C- gamma . -2.6
99893_at AF020737 Fgf13 fibroblast growth factor 13 . -2.6
93134_at U62021 Nptx1 neuronal pentraxin 1 . -3.0
98806_s_at U52824 tub tubby . -3.2
99557_at AI849565 Nelf nasal embryonic LHRH factor . -3.3
101969_at D50263 Nbl1 neuroblastoma- suppression of tumorigenicity 1 . -3.7
102156_f_at M80423 Igk-C IgK chain gene, C-region . 4.1
93086_at M18237 Igk-V28 immunoglobulin kappa chain variable 28 (V28) . 2.9
92945_at L32372 Gria2 glutamate receptor, ionotropic, AMPA2 (a2) . 1.8
96011_at AB009275 Matr3 matrin 3 . 1.8
162255_s_at AV336781 Scn1a sodium channel- voltage-gated- type I- alpha polypeptide . 1.6
160103_at AW212859 Axot axotrophin . 1.6
102235_at X13945 Lmyc1 lung carcinoma myc related oncogene 1 . -1.6
94246_at J04103 Ets2 E26 avian leukemia oncogene 2- 3' domain . -1.6
95466_at AI837006 Clp coactosin-like protein . -2.5
95350_at D00073 Ttr Ttr 4.5 -4.2 1.6
97317_at AW122933 Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 2.2 -1.6
4              
var.
4    
var.
1        
 75%
2          
50%
3  
unique
1     
 75% 
2    
50%
3 
unique
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that differed between the senescence-prone and -resistant
strains (Figure 3b).
The genes differentially expressed between the senescence-
prone and -resistant strains could be early markers for aging,
or may establish the foundation for accelerated senescence in
the S8 and S10 strains. Several of these genes fell into inter-
esting Gene Ontology (GO) categories, as determined by gene
enrichment analysis using the GO Tree Machine [37,38]. In
the hippocampus, these included genes involved in learning
and behavior (phosphodiesterase 1B; Ca2+-calmodulin
dependent, protein kinase C-gamma; and preproenkephalin
1), and genes involved in the heat-shock response (heat-shock
70 kD protein 5 (glucose-regulated protein); heat-shock pro-
tein 1B; and heat-shock protein 2). In the retina, genes fell
into categories involved in the perception of light (ATP-bind-
ing cassette, subfamily A (ABC1), member 4; prominin 1
phosphodiesterase 6A, cGMP-specific, rod, alpha; and retinal
G-protein-coupled receptor), chloride transport (chloride
channel 4-2; gamma-aminobutyric acid (GABA-A) receptor,
subunit beta 3; solute carrier family 12, member 2; and chlo-
ride intracellular channel 4 (mitochondrial)) and lipid metab-
olism (ATP-binding cassette, subfamily A (ABC1), member 1;
ATP-binding cassette, subfamily A (ABC1), member 4; glyc-
erol kinase; peroxisome proliferator activated receptor alpha;
prostaglandin D2 synthase (brain); retinol binding protein 1,
cellular; sterol-C5-desaturase (fungal ERG3, delta-5-desatu-
rase) homolog; and sterol-C4-methyl oxidase-like).
To establish the real-world performance of both the analytical
methodologies and experimental procedures used to identify
gene expression changes, ten genes were chosen from the hip-
pocampal analysis for quantitative reverse transcription PCR
(qRT-PCR) verification using independent samples (from
mice not used in the microarray analysis) (indicated with ‡ in
Figure 3). Of the ten genes assayed, the expression changes
for eight genes were confirmed with a change of 1.3-fold or
greater: intracisternal-A particles (Iap), upstream transcrip-
tion factor 1 (Usf1), potassium voltage-gated channel, sub-
family Q, member 2 (Kcnq2), chemokine (C-C motif) ligand
19 (Ccl19), erythroid differentiation regulator (edr), caspase 9
(Casp9), chemokine (C-C motif) ligand 27 (Ccl27), comple-
ment and component 4 (C4). Of the remainder, one showed a
similar trend (1.2-fold change, chromobox homolog 3 (Dro-
sophila HP1 gamma) (Cbx3)) and one (ATP-binding cassette,
subfamily D (ALD), member 3 (Abcd3)), showed no gene-
expression change, and thus represents a possible false
positive.
To cross-validate the gene-expression results, a method
besides qRT-PCR was used to examine the expression levels
of two genes identified as differentially expressed. In situ
hybridization was performed on S8, S10, and SR1 mice for the
regulator of G-protein signaling 5 (Rgs5) and Iap. Gene-
expression profiling showed that Rgs5  was more highly
expressed in the hippocampus and retina of S8 than SR1. In
situ hybridization confirmed that Rgs5 was more abundant in
the hippocampus and retina of S8 mice than SR1, and also
revealed an increased level of Rgs5  in the S8 cerebellum
(Figure 4a). The other transcript studied in this manner, Iap
had a two- to five-fold higher expression level in both S8 and
S10 relative to SR1 mice in the hippocampus and retina. In
situ hybridization clearly showed an increased signal in S8
and S10 hippocampus and retina relative to SR1. In contrast
to Rgs5, no difference was seen in the cerebellum (Figure 4b).
For both transcripts, the in situ hybridization results were
correlated with the microarray analyses, indicating a high
degree of confidence in those results. Additionally, the pat-
tern of expression observed in the in situ experiments
suggests that the higher signal resulted from increased tran-
script levels in cells that normally express the gene, not
ectopic expression in unusual cell types.
Inter-strain, age-independent gene-expression changes Figure 3 (see following page)
Inter-strain, age-independent gene-expression changes. (a) A heat-map view of genes differentially expressed in hippocampus with either S8 compared to 
SR1, or S10 compared to SR1 is shown. Columns indicate fold change in gene expression between young S8 and SR1, young S10 and SR1, old S8 and SR1 
and old S10 and SR1, respectively. Bright red and bright green indicate genes that met the most stringent criteria for an increased or decreased expression 
level change, including a WSRR p < 0.01. A gene is colored orange or light green if it was increased or decreased with an average WSRR p < 0.05 in all 
comparison files. Boxes, numbers and examples of genes with the pattern of change are as follows: group 1, genes differentially expressed between both 
young and old S8 and S10 mice compared to SR1, example gene is melanoma antigen, 80 kDa; group 2, genes differentially expressed in 3/4 comparisons of 
young and old S8 and S10 compared to SR1, example gene is decorin; group 3, genes differentially expressed in either young and old S8 versus SR1 or 
young and old S10 versus SR1, example gene is heat shock 70 kD protein 5; group 4, genes differentially expressed in any single comparison group of S8 or 
S10 to SR1, example gene is protein phosphatase 1-1A (differences unique to a single age and strain); group 5, genes with inconsistent expression 
differences, example genes are RAN binding protein 9, glutathione S-transferase a4 and kinesin family member 5b. Genes differentially expressed in both 
retina and hippocampus are indicated by an asterisk. Gene-expression differences confirmed by qRT-PCR are indicated by the symbol ‡. Line graphs in the 
last column represent the signal intensity on the y-axis and the time point of collection on the x-axis. S8 is indicated by a red line, S10 by a blue line, SR1 by 
a green line and B6J by a black line. (b) Heat-map view and line graphs of exemplars from each group representing differentially expressed genes in the 
retina between S8 versus SR1 and S10 versus SR1 mice is shown. Analysis and representation of the data is similar as described for (a).http://genomebiology.com/2005/6/6/R48 Genome Biology 2005,     Volume 6, Issue 6, Article R48       Carter et al. R48.7
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Using both qRT-PCR and in situ hybridization, 10/11 genes
identified as differentially expressed using Affymetrix
oligonucleotide microarrays were confirmed using independ-
ent samples and independent methods.
A cluster of genes on chromosome 4, including Ccl19, is 
differentially expressed between S8 and SR1 mice
Because the gene-expression differences between the acceler-
ated-senescence prone and resistant strains are consistent in
Figure 3 (see legend on previous page)
Probe Set Acc # Symbol Gene
S8 
vs 
SR
S10 
vs 
SR
S8  
vs  
SR
S10 
vs 
SR Probe Set Acc # Symbol Gene
S8 
vs 
SR
S10 
vs 
SR
S8 
vs 
SR
S10 
vs 
SR
97282_at * D10049 Mela melanoma antigen- 80 kDa 14.1 5.1 26.9 26.4 93909_f_at * X04120 Iap intracisternal A particles 5.7 5.7 3.9 4.4
93568_i_at * AI853444 2610042L04Rik RIKEN cDNA 2610042L04 gene 2.7 2.5 2.5 2.3 95430_f_at * AI854154 D9Wsu18e est 2.8 3.1 3.5 3.8
93909_f_at * X04120 Iap intracisternal A particles  2.0 3.1 1.9 2.8 98369_f_at * AW048053 2610028J07Rik RIKEN cDNA 2610028J07 gene 2.1 2.5 2.1 2.2
102761_at * AF041060 Grpel2 GrpE-like 2- mitochondrial 2.8 2.6 2.7 2.2 101883_s_at * L22977 Xlr3b X-linked lymphocyte-regulated 3b 1.8 2.7 3.9 2.0
94364_at * AI847926 Selel selectin- endothelial cell- ligand -1.7 -2.0 -2.6 -3.1 94445_at AW125273 AI115446 expressed sequence AI115446 1.7 1.5 1.9 1.6
103033_at X06454 C4 complement component 4  -1.9 -1.6 -2.6 -1.9 101451_at * AF038939 Peg3 paternally expressed 3 -3.9 -3.9 -4.2 -4.4
160474_at * AW046278 2610511E03Rik RIKEN cDNA 2610511E03 gene -4.7 -4.0 -3.4 -3.6 101886_f_at X52490 H2-D histocompatibility 2- D region -3.1 -2.0 -2.2 -1.8
95430_f_at * AI854154 D9Wsu18e est 3.8 3.1 2.6 94364_at * AI847926 Selel selectin- endothelial cell- ligand -1.6 -1.5 -1.5 -1.6
101887_at AF045887 Agt angiotensinogen 1.6 2.0 2.3 101560_at AW061330 Emb embigin -2.6 -2.3 -2.0 -2.4
104374_at M64086 Spi2-2 serine protease inhibitor 2-2 1.5 1.5 4.1 97540_f_at * M69069 H2-D1 histocompatibility 2- D region locus 1 -2.3 -1.4 -1.7 -1.5
93534_at X53929 Dcn decorin 1.5 1.6 4.7 94208_at * AW045202 1700015E05Rik RIKEN cDNA 1700015E05 gene 2.3 1.6 1.2
93656_g_at X95316 USF1 upstream transcription factor 1  -2.5 -2.4 -1.9 103828_at AF100956 Sacm2l suppressor of actin mutations 2, homolog-like  1.6 1.7 1.9
93860_i_at M17327 MMLV mouse endogenous murine leukemia virus  -1.5 -1.8 -1.9 94027_at AA815831 Cd84 CD84 antigen -1.6 -1.6 -1.4
98782_at D38613 Cplx2 complexin 2 -1.8 -2.2 -1.9 95530_at AW060250 6330549H03Rik RIKEN cDNA 6330549H03 gene 1.7 1.6 1.7
96215_f_at * AI153421 nd est 2.6 2.3 2.1 93568_i_at * AI853444 2610042L04Rik RIKEN cDNA 2610042L04 gene 1.7 2.1 2.4
99450_at AB000503 Kcnq2 K+ voltage-gated channel- Q2  -1.9 -2.6 -1.9 104217_at AW045753 1110015E22Rik RIKEN cDNA 1110015E22 gene 1.9 2.5 1.8
93838_at AI846994 2700038C09Rik RIKEN cDNA 2700038C09 gene -2.2 -2.2 -2.5 103562_f_at * M26005 gag Mouse endogenous retrovirus truncated gag protein 4.2 3.5 4.5
103562_f_at * M26005 MMLV mouse endogenous murine leukemia virus  2.8 3.5 3.6 101787_f_at X16672 nd nd 1.8 2.0 2.0
101451_at * AF038939 Peg3 paternally expressed 3 -1.5 -4.1 -5.2 93120_f_at V00746 H2-K histocompatibility 2, K region -2.4 -2.1 -1.8
103235_at AI848386 0710005A05Rik RIKEN cDNA 0710005A05 gene -2.2 -1.8 -2.1 100696_at X60664 Pde6a phosphodiesterase 6A- cGMP-specific- rod A -1.7 -1.9 -2.1
94208_at * AW045202 1700015E05Rik RIKEN cDNA 1700015E05 gene 2.5 2.5 93861_f_at M17327 MMLV Mouse endogenous murine leukemia virus -1.8 -1.5 -1.8
101955_at AJ002387 Hspa5 heat shock 70kD protein 5 2.2 1.9 160474_at * AW046278 2610511E03Rik RIKEN cDNA 2610511E03 gene -4.2 -2.2 -3.0
101883_s_at * L22977 Xlr3b X-linked lymphocyte-regulated 3b 1.8 3.6 102360_at AW214225 AI323986 expressed sequence AI323986 -1.8 -2.1 -1.6
94821_at AW123880 Xbp1 X-box binding protein 1 1.9 1.6 92545_f_at AB006361 Ptgds prostaglandin D2 synthase (21 kDa- brain) -2.3 -5.0 -4.5
100946_at AF109906 nd nd 2.1 1.5 93482_at AI117835 AW489456 expressed sequence AW489456 -1.5 -1.4 -2.0
96060_at U25844 Serpinb6 serpin clade B (ovalbumin)-member 6 1.7 1.4 95095_at U90435 Flot1 flotillin 1 1.9 1.6
95749_at AW122364 Armet arginine-rich- mutated in early stage tumors 2.1 2.0 99897_at U14420 Gabrb3 (GABA-A) receptor-beta 3 1.5 1.5
161361_s_at AV213431 Tnnt1 troponin T1- skeletal- slow -4.4 -3.4 102761_at * AF041060 Grpel2 GrpE-like 2- mitochondrial 2.3 2.3
93284_at D78135 Cirbp cold inducible RNA binding protein -1.7 -1.5 99500_at U13174 Slc12a2 solute carrier family 12- member 2 2.2 2.3
96041_at AB016424 Rbm3 RNA binding motif protein 3 -1.5 -1.6 94255_g_at AI845237 Clic4 chloride intracellular channel 4 (mitochondrial) 2.9 2.0
93137_at U51908 Ntsr2 neurotensin receptor 2 -1.6 -1.5 160894_at X61800 Cebpd CCAAT/enhancer binding protein (C/EBP)- delta 2.3 2.1
93714_f_at AI117211 H2-L histocompatibility 2- L region -3.8 -3.4 160399_r_at AA646966 H2afy H2A histone family- member Y 1.4 1.7
93134_at U62021 Nptx1 neuronal pentraxin 1 2.3 1.6 98579_at M28845 Egr1 early growth response 1 -2.9 -3.5
93382_at AF023343 Pde1b phosphodiesterase 1B -3.8 -2.5 95331_at AF076930 Rgr retinal G protein coupled receptor -3.7 -3.8
97844_at U67187 Rgs2 regulator of G-protein signaling 2 -3.7 -1.7 160901_at * V00727 c-fos FBJ osteosarcoma oncogene -1.9 -2.2
94516_f_at M55181 Penk1 preproenkephalin 1 -11.6 -4.2 101308_at M64228 Kcnb1 K+ voltage gated channel-Shab-related 1 -1.6 -1.8
98300_at * AJ010949 Cacna2d3 Ca channel- voltage dependent- a2/d subunit 3 -1.9 -1.7 94288_at J03482 Hist1h1c histone 1, H1c -1.7 -1.4
96950_at * AW120505 CCL19 chemokine (C-C motif) ligand 19  5.9 8.2 99392_at U19463 Tnfaip3 tumor necrosis factor- alpha-induced protein 3 -1.9 -1.5
94522_at * AF098508 Dctn3 dynactin 3 2.7 2.9 97317_at * AW122933 Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 -2.3 -1.5
93045_at * L28836 Abcd3 ATP-binding cassette, D 3  2.6 2.6 100099_at Z14132 Smpd1 sphingomyelin phosphodiesterase 1, acid lysosomal -1.6 -1.6
102194_at AW122332 2810432D09Rik RIKEN cDNA 2810432D09 gene 2.1 2.5 94375_at Y11666 Hk2 hexokinase 2 -1.4 -1.6
100972_s_at AW124975 CCL27 chemokine (C-C motif) ligand 27  2.0 1.6 94522_at * AF098508 Dctn3 dynactin 3 4.0 3.7
103534_at V00722 Hbb-b2 hemoglobin, beta adult minor chain 1.9 1.7 93045_at * L28836 Abcd3 ATP-binding cassette, sub-family D (ALD), member 3 2.6 2.6
98617_at AF071186 Wbp11 WW domain binding protein 11 1.7 2.2 104616_g_at M96265 Galt galactose-1-phosphate uridyl transferase 2.0 1.8
94828_at * AF004927 Oprs1 opioid receptor- sigma 1 1.6 2.2 100973_i_at AA672499 CCL27 small inducible cytokine A27 1.7 1.7
96114_at AW122076 Ppp1r1a protein phosphatase 1-regulatory subunit 1A -3.6 -7.1 96199_at AF073996 Mtm1 X-linked myotubular myopathy gene 1 2.1 1.7
98525_f_at * AJ007909 edr erythroid differentiation regulator  -2.6 -3.0 160754_at AI850363 Pygm muscle glycogen phosphorylase 1.3 1.5
95350_at D00073 Ttr transthyretin -3.1 4.3 98525_f_at * AJ007909 edr erythroid differentiation regulator -1.9 -2.1
93785_at M64782 Folr1 folate receptor 1 (adult) -3.1 2.8 96650_at AI837724 Auh AU RNA binding protein/enoyl-coenzyme A hydratase -1.9 -1.6
103523_at AI851703 AW049671 expressed sequence AW049671 -1.7 -2.8 160417_at * U86090 Kif5b kinesin family member 5B -2.1 -1.7
100405_at * X56683 Cbx3 chromobox homolog 3  4.7 4.8 98438_f_at X16202 H2-Q7 histocompatibility 2, Q region locus 7 -2.3 -2.2
100368_at AB019601 Casp9 caspase 9  3.3 3.3 100405_at * X56683 Cbx3 chromobox homolog 3 (Drosophila HP1 gamma) 4.4 4.1
97759_at * U09383 Kcnma1 K+ large conductance Ca-activated channel- Ma1 2.7 4.2 160190_at U10355 Syt4 synaptotagmin 4 3.1 3.4
98958_at AA759910 4921532K09Rik RIKEN cDNA 4921532K09 gene 2.6 2.8 97759_at * U09383 Kcnma1 K+ large conductance Ca-activated channel- Ma1 3.0 2.5
99779_at N28141 D6Bwg1452e est 2.5 2.1 102668_at X57638 Ppara peroxisome proliferator activated receptor alpha 2.3 4.5
98254_f_at AW209004 nd nd 2.2 2.0 98300_at * AJ010949 Cacna2d3 Ca channel- voltage dependent- alpha2/delta 3 2.3 2.0
98369_f_at * AW048053 2610028J07Rik RIKEN cDNA 2610028J07 gene 2.1 1.8 104035_at AW123795 C77863 expressed sequence C77863 1.8 1.5
93592_at X82648 Apod apolipoprotein D 2.1 1.7 99186_at X75483 Ccna2 cyclin A2 1.7 1.6
98626_at AW047503 1810017G16Rik RIKEN cDNA 1810017G16 gene -1.4 -1.6 93389_at AF039663 Prom prominin 1.6 1.4
100958_at AI647003 C79050 EST C79050 -1.7 -2.1 101709_at AB015140 Ahrr aryl-hydrocarbon receptor repressor 5.1 9.4
103294_at U67188 Rgs5 regulator of G-protein signaling 5 5.6 161703_f_at AV003419 Anxa1 annexin A1 2.1 7.7
104537_at AW048828 0610042C05Rik RIKEN cDNA 0610042C05 gene 1.8 102768_i_at AB016248 Sc5d sterol-C5-desaturase (fungal ERG3- delta-5-desaturase) 2.1 2.8
97812_at * AF006465 Ranbp9 RAN binding protein 9 1.8 98524_f_at AI848479 2210039B01Rik RIKEN cDNA 2210039B01 gene 1.4 1.6
99521_at AB020239 Ak4 adenylate kinase 4 1.7 97916_at AI116222 5730494N06Rik RIKEN cDNA 5730494N06 gene 1.4 1.5
96560_at AA648027 nd EST 1.7 104313_at AI842432 2610020G18Rik RIKEN cDNA 2610020G18 gene -1.7 -2.1
94343_at AI604013 nd nd 1.6 99140_at AW124920 Mrpl16 mitochondrial ribosomal protein L16 -1.9 -2.0
92871_at AW121840 AW493766 expressed sequence AW493766 1.6 104591_g_at L13171 Mef2c myocyte enhancer factor 2C -2.1 -2.0
93323_at AB031292 Plp2 proteolipid protein 2 -1.5 104518_at AJ239052 Cryba1 crystallin- beta A1 -2.7 1.7
98623_g_at X71922 Igf2 insulin-like growth factor 2 -1.7 97282_at * D10049 Mela melanoma antigen- 80 kDa 4.9
94365_at AA710175 1190005L05Rik RIKEN cDNA 1190005L05 gene -1.7 96950_at * AW120505 CCL19 small inducible cytokine A19 2.9
97317_at * AW122933 Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 -1.8 94980_at AI006319 2010300F21Rik RIKEN cDNA 2010300F21 gene 2.6
97540_f_at * M69069 H2-D1 histocompatibility 2- D region locus 1 -2.5 97834_g_at AI853802 Pfkp phosphofructokinase- platelet 2.1
102345_at D83921 Ebaf endometrial bleeding associated factor -5.1 95359_at M18186 Hsp84-1 heat shock protein- 84 kDa 1 1.7
103580_at AI845588 AA589616 expressed sequence AA589616 2.1 96254_at AB028272 Dnajb1 DnaJ (Hsp40) homolog- subfamily B- member 1 1.6
104260_at AW123061 AW112037 expressed sequence AW112037 1.8 94828_at * AF004927 Oprs1 opioid receptor- sigma 1 1.6
94406_at AJ242864 Phtf putative homeodomain transcription factor 1.7 97812_at * AF006465 Ranbp9 RAN binding protein 9 1.6
92388_at AW045528 nd est -1.7 97666_r_at C76213 C76213 expressed sequence C76213 -4.6
103526_at D16580 Padi2 peptidyl arginine deiminase- type II -1.8 96295_at AW122030 Psat phosphoserine aminotransferase -1.6
104432_at AF016482 Arhn ras homolog N (RhoN) -1.9 103489_at AA921481 Soc socius -1.7
104136_at AI840413 nd est -1.9 160337_at AI847162 1300017C10Rik RIKEN cDNA 1300017C10 gene -1.7
160841_at AW047343 Dbp D site albumin promoter binding protein -2.1 100688_at M60559 Crybb2 crystallin- beta B2 -1.9
99557_at AI849565 Nelf nasal embryonic LHRH factor 2.8 103811_at AJ010902 Invs inversin 1.9
96085_at L06047 Gsta4 glutathione S-transferase- alpha 4 2.3 97525_at U48403 Gyk glycerol kinase -1.6
95393_at AI503362 nd est 2.2 96017_at AA710907 0610006I08Rik RIKEN cDNA 0610006I08 gene -1.6
93648_at L28035 Prkcc protein kinase C- gamma 2.2 104704_at AI837630 Clcn4-2 chloride channel 4-2 -1.6
93188_at AJ243964 Dkk3 dickkopf homolog 3 (Xenopus laevis) 2.0 99109_at M59821 Ier2 immediate early response 2 -1.7
98627_at X81580 Igfbp2 insulin-like growth factor binding protein 2 2.0 97730_at AF000149 Abca4 ATP-binding cassette- sub-family A4 -1.8
99816_at M20567 Hspa2 heat shock protein 2 2.0 100927_at U28960 Pltp phospholipid transfer protein -1.7
99010_at AB024538 Islr Ig superfamily containing leucine-rich repeat 1.9 99401_at Y10725 Kist kinase interacting with leukemia-associated gene (stathmin) -1.9
104559_at AI848162 BC003940 phosphotyrosyl phosphatase activator 1.9 101447_at M88127 Apc adenomatosis polyposis coli -2.3
102342_at U10120 Nsf N-ethylmaleimide sensitive fusion protein 1.8 97752_at AI854265 AI854265 expressed sequence AI854265 5.4
160273_at AA960603 Zfp36l2 zinc finger protein 36- C3H type-like 2 -1.6 103285_at AF072249 Mbd4 methyl-CpG binding domain protein 4 5.0
98025_at M34896 Evi2 ecotropic viral integration site 2 -1.7 100046_at J04627 Mthfd2 methylenetetrahydrofolate dehydrogenase (NAD+ dependent) 4.0
103551_at AW124208 AI428202 EST AI428202 -1.8 160990_r_at AA170696 Icam1 intercellular adhesion molecule 2.4
100536_at AI839662 R74645 expressed sequence R74645 -1.8 94433_at AW060684 AI316867 expressed sequence AI316867 2.2
104386_f_at AI843901 1110004F14Rik RIKEN cDNA 1110004F14 gene -1.8 100471_at AW048916 AI413214 expressed sequence AI413214 2.1
96144_at AJ001972 Idb4 inhibitor of DNA binding 4 -1.8 94809_at U52945 tsg101 tumor susceptibility gene 101 2.1
98553_at AW124175 Slap sarcolemmal-associated protein -1.8 103891_i_at AI197161 Ell2 ELL-related RNA polymerase II, elongation factor 1.9
95493_at X66405 Col6a1 procollagen- type VI- alpha 1 -1.9 160388_at AI848668 Sc4mol sterol-C4-methyl oxidase-like 1.9
104123_at AW120727 3322402E17Rik RIKEN cDNA 3322402E17 gene -2.0 103021_r_at AI317205 Map3k1 mitogen activated protein kinase kinase kinase 1 1.9
103416_at AI844810 Mapk6 mitogen-activated protein kinase 6 -2.1 104761_at AA612450 2310046B19Rik RIKEN cDNA 2310046B19 gene 1.8
100435_at U13370 Edg2 endothelial diff.-lysophosphatidic acid GPCR 2 -2.1 94354_at AI845514 Abca1 ATP-binding cassette- sub-family A1 1.8
99149_at AI851230 2310035M22Rik RIKEN cDNA 2310035M22 gene -2.2 95232_at AB009392 Hnrpl heterogeneous nuclear ribonucleoprotein L 1.7
102725_at AF033003 Kcnab1 K+ voltage-gated channel- shaker-related B1 -2.2 100603_at AF063231 Dncic2 dynein- cytoplasmic- intermediate chain 2 1.7
102371_at X16995 Nr4a1 nuclear receptor subfamily 4, A1 -2.5 104155_f_at U19118 Atf3 activating transcription factor 3 1.7
94321_at V00830 Krt1-10 keratin complex 1- acidic- gene 10 -2.5 104706_at U69171 Pex7 peroxisome biogenesis factor 7 1.7
96302_at AA711516 nd est -2.6 98048_at AF060490 Nssr neural-salient serine/arginine-rich 1.6
104407_at L25274 Alcam activated leukocyte cell adhesion molecule -2.7 102058_at AI845667 Mrpl9 mitochondrial ribosomal protein L9 1.6
98409_at L00923 Myo1b myosin Ib -2.8 160533_r_at X12521 Tnp1 transition protein 1 -1.6
97302_at AI854285 Nd1 Nd1 -2.8 100498_g_at D38375 Stx3 syntaxin 3 -1.6
93985_at AW120868 AW558171 expressed sequence AW558171 -2.8 93211_at AF032115 Dnajc5 DnaJ (Hsp40) homolog- subfamily C5 -1.6
100003_at D38216 Ryr1 ryanodine receptor 1- skeletal muscle -3.0 104716_at X60367 Rbp1 retinol binding protein 1- cellular -1.8
99342_at M60596 Gabrd GABA-A receptor, subunit delta -3.0 103910_at AJ249987 Taf10 TAF10 RNA pol II, TBP-associated factor -2.1
160417_at * U86090 Kif5b kinesin family member 5B -3.6 97895_f_at AW125218 2410071B14Rik RIKEN cDNA 2410071B14 gene -6.7
103282_at U78171 Rasgrp2 RAS- guanyl releasing protein 2 -5.6 96215_f_at * AI153421 nd est 2.2 1.8
93615_at AF020200 Pbx3 pre B-cell leukemia transcription factor 3 -6.0 102335_at AF033017 Kcnk1 potassium channel- subfamily K- member 1 1.8 1.8
99386_at M88301 Pou3f4 POU domain, class 3, transcription factor 4 -6.1 94781_at * V00714 Hba-a1 hemoglobin alpha, adult chain 1 2.4 -2.5
97260_at AW121489 Arpp19 cyclic AMP phosphoprotein- 19 kDa -8.6 101869_s_at * J00413 Hbb-b1 Hbb-b1 1.9 -2.5
100458_at X61450 Brp14 brain protein 14 2.9
94144_g_at X02801 Gfap glial fibrillary acidic protein 2.6
95559_at AI838836 6330403K07Rik RIKEN cDNA 6330403K07 gene -1.8
96226_at AI841843 AI841843 expressed sequence AI841843 -2.3
96784_at AW123269 1110037A17Rik RIKEN cDNA 1110037A17 gene 2.0 -3.0
160901_at * V00727 c-fos FBJ osteosarcoma oncogene 1.8 -2.4
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multiple independent animals, we sought to identify genetic
differences between the strains that might mediate these
expression level differences. To identify patterns of expres-
sion related to gene position, we looked for correlations
between gene location and expression difference. This analy-
sis revealed an interesting region on chromosome 4 of S8
m i c e  h a r b o r i n g  m u l t i p l e  g e n e s  t h a t  w e r e  m o r e  h i g h l y
expressed in S8 than SR1 (Figure 5). The RNA levels for six
genes in retina or hippocampus were higher in S8 than SR1,
representing 21% (6/29) of the S8-SR1 specific hippocampal
gene expression differences and 26% (5/19) of the retinal
differences. The identified genes were Ccl19, Ccl27, dynactin
3 (Dctn3), opioid receptor, sigma 1 (Oprs1), galactose-1-phos-
phate uridyl transferase (Galt), and 2810432D09Rik, all of
which are within less than 100 kb of each other on chromo-
some 4 (based on the Celera mouse genome database). Ccl19
was not formally localized to this region but has been shown
to be located near Ccl27 [39,40]. These genes are more highly
expressed by a factor of 1.7 to 7.4 in S8 relative to SR1 mice.
The physical clustering of differentially expressed genes may
indicate involvement of a large-scale chromosomal regulatory
mechanism.
To investigate this cluster of differentially expressed genes,
we pursued one of them in more detail: Ccl19. Our gene-
expression studies indicated an increased level of mRNA in
the S8 hippocampus relative to SR1. To examine Ccl19
expression in the SAM strains more closely, northern analysis
was performed on spleen and hippocampus RNA (Figure 6a).
Whereas a consistent band was detected in the spleen of all
three SAM strains (Figure 6a, lower band), a band was
detected only in the hippocampus of S8 mice (consistent with
the gene-expression data). Interestingly, the transcript found
in the S8 hippocampus was larger than that seen in the
spleen, suggesting either tissue-specific alternative splicing
from a single gene locus or the presence of a novel expressed
locus.
Motivated by reports that some strains of mice can harbor
nearby pseudogenes of Ccl19 [39,40] and the different size of
the transcript identified in the S8 hippocampus, sequence
analysis was performed on Ccl19 cDNA from both hippocam-
pus and spleen of S8, S10 and SR1 mice. While no bands were
identified by northern analysis in the hippocampus of S10 or
SR1, fragments were obtained from these tissues using the
more sensitive method of reverse-transcriptase PCR.
Sequencing of fragments amplified from cDNA revealed an
altered coding sequence for the S8 hippocampus transcript
relative to all other transcripts, including that found in S8
spleen. The predicted amino-acid sequence of the transcript
unique to the S8 hippocampus had two mutations relative to
the canonical Ccl19 sequence: a point mutation eliminating
the canonical start ATG of Ccl19 and a substitution mutation
resulting in a novel methionine 47 residues further down-
stream in the S8 hippocampus transcript (Figure 6b). Inter-
estingly, while we found no prior description of the novel
methionine, the mutation in the canonical start ATG has been
previously described in unexpressed Ccl19  pseudogenes
found in other strains of mice [39,40]. It is possible that the
novel downstream ATG identified in the Ccl19 transcript from
the S8 hippocampus may provide a compensatory in-frame
start site allowing expression of a truncated protein. No dif-
ferences within the coding sequence were identified that
could result in the larger transcript observed in the S8 hip-
pocampus, suggesting that the longer mRNA results from
additional 5' or 3' untranslated region (UTR) sequence.
Because Ccl19 was one of several up-regulated genes located
in proximity to one another and because sequence differences
between S8 Ccl19 hippocampus and spleen mRNA suggested
expression from at least two distinct genes, we hypothesized
that a genomic duplication encompassing Ccl19  and sur-
In situ hybridization of Rgs5 and Iap Figure 4
In situ hybridization of Rgs5 and Iap. (a) In situ hybridization of an Rgs5 
probe to SR and S8 hippocampus (A, D), cerebellum (B, E) and retina (C, 
F) is shown. Increased levels of expression can be seen in all three tissues 
of S8 mice relative to SR1 mice. (b) In situ hybridization of an Iap probe to 
SR, S8 and S10 hippocampus (A, D, G), cerebellum (B, E, H) and retina (C, 
F, I) are shown. Increased expression levels of Iap can be seen in the 
hippocampus and retina of S8 and S10 mice relative to SR1 mice.
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rounding genes was present within the S8 genome. Indeed,
Southern analysis using a Ccl19 probe demonstrated a two-
fold increase in signal intensity in S8 mice relative to S10 and
SR1, consistent with such a duplication (Figure 6c, d). The
Southern analysis and sequence information from S8 mice
are consistent with a duplication of a block of genes on chro-
mosome 4, resulting in increased expression.
Fgf1 is mutated in S10 mice
As no large-scale genomic sequencing has been reported for
either S10 or SR1, we used an algorithm developed in our lab-
oratory that takes advantage of the fact that Affymetrix Gene-
Chips use a series of oligonucleotides that span up to
hundreds of bases of a given gene to detect potential sequence
variations between the strains (J.A.G., M.A. Zapala, C.B. and
D.J.L., unpublished data, see Materials and methods). These
oligonucleotides (called probes) yield distinct patterns of
intensity for each gene. Sequence differences can be detected
based on differences in the hybridization pattern across the
set of probes between samples. We compared the underlying
patterns of signal intensity between the SAM strains to iden-
tify genes that may harbor sequence differences between
strains [35] (J.A.G., M.A. Zapala, C.B.and D.J.L., unpub-
lished data, see Materials and methods). These oligomers
(probe pairs, 11-20 per gene) yield distinct patterns of inten-
sity for each gene. The probe pairs are sensitive enough that
appropriately positioned single base differences between the
probe pair and the detected RNA can significantly change the
signal intensity, and thus produce different patterns between
slightly different sequences. We compared these underlying
patterns of signal intensity between the SAM strains to iden-
tify genes harboring candidate sequence differences between
strains [35] (J.A.G., M.A. Zapala, C.B. and D.J.L.,
unpublished data, see Materials and methods). Using a
threshold p-value of p < 0.000001 (calculated from a two-
tailed Student's t-test (unpaired, equal variance)), 20 tran-
scripts were predicted to harbor sequence differences (possi-
bly including nucleotide substitutions, splice differences and/
or deletions/insertions) in S8, 36 genes in S10, and 17 genes
in both S8 and S10 relative to SR1 (see Additional data file 4).
We have found previously that genes containing at least two
predicted polymorphisms (even in the 3' UTR of a gene) often
contain additional sequence variations (data not shown).
Therefore, we sequenced the coding regions of several genes
containing predicted sequence differences between S10 and
SR1 that are also known to be involved in important cellular
pathways. This led to the identification of mutations in the
fibroblast growth factor 1 (Fgf1) gene in S10 mice. Sequencing
of the Fgf1  transcript confirmed the predicted polymor-
phisms in the 3' UTR in S10 (T-C at base pair 2,190 and C-T
at base pair 2,931, reference sequence: AF067197). Of partic-
ular importance, further sequencing into the coding region of
Fgf1 revealed a 15-nucleotide insertion that alters the coding
sequence and is expected to result in a truncated protein lack-
ing approximately 45% of the conserved Fgf1 domain (Figure
S8-specific cluster of differentially expressed genes on chromosome 4 Figure 5
S8-specific cluster of differentially expressed genes on chromosome 4. The location and relative expression levels of a cluster of differentially expressed 
genes on chromosome 4 containing a cluster of differentially expressed genes in S8 mice are depicted. FC, fold change, represents the average fold change 
in S8 relative to SR hippocampus (Hp) and retina (Rt). Those gene-expression changes significant to a p-value ≤  0.05 (WSRR) are indicated and those genes 
that were not significantly different are marked as nonsignificant (ns). Chromosomal map position is given in megabases, and both the Affymetrix ID and 
LocusLink gene symbol are specified. The genes demonstrating upregulation in S8 mice are highlighted in gray.
Position (Mb) Gene Affy. ID FC-Hp p-value FC-Rt p-value
38.360-37.430 Il11ra2 93874_s_at 1.3 n.s. 1.2 n.s.
38.375-38.383 Dctn3 94522_at 2.8 p = 0.001 3.9 p = 0.001
--- AW122332 102194_at 2.3 p = 0.002 1.7 p = 0.007
38.399-38.402 Oprs1 94828_at 2.0 p = 0.009 1.7 p = 0.014
38.416-38.419 GALT 104616_g_at -1.1 n.s. 1.9 p = 0.012
38.430-38.436 Ccl27 100972_s_at 1.7 p = 0.003 2.0 p = 0.012
--- Ccl19 96950_at 7.4 p = 0.001 2.9 p = 0.017
39.979-39.988 Dnajb5 102620_at 1.2 n.s. -1.9 n.s.
39.995-40.062 Stom12 96289_at 1.2 n.s. -1.1 n.s.
40.010-40.030 Vcp 100710_at 1.3 n.s. 1.2 n.s.
--- C76213 97666_r_at -6.0 p = 0.030 -4.3 p = 0.040
40.032-40.040 Fancg 103530_at -2.1 n.s. -2.3 p = 0.014
40.088-40.293 Unch13h1 92496_at -1.5 n.s. 1.1 n.s.
40.477-40.481 Tesk1 102033_at -1.7 n.s. -1.5 n.s.
40.565-40.590 Tln 99448_at -1.2 n.s. -1.1 n.s.
40.688-40.691 AA710175 94365_at -1.4 p = 0.018 -1.5 n.s.R48.10 Genome Biology 2005,     Volume 6, Issue 6, Article R48       Carter et al. http://genomebiology.com/2005/6/6/R48
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Ccl19 is abnormally expressed in S8 hippocampus and is duplicated Figure 6
Ccl19 is abnormally expressed in S8 hippocampus and is duplicated. (a) A northern blot of total RNA from spleen and hippocampus after hybridization 
with a Ccl19-specific probe is shown. An abnormally large Ccl19 transcript is detected only in the hippocampus of S8 mice, while the spleen of S8, S10 and 
SR1 all show normal Ccl19 expression. (b) Predicted amino-acid sequence of CCL19 from the hippocampal cDNA sequence of S8 mice reveals a putative 
truncation at the amino terminus of the protein relative to that of S8 spleen, and SR1 spleen and hippocampus. Arrows indicate the sites of mutations in 
the protein found in the S8 hippocampus. The region of the protein deleted by the mutations is highlighted in yellow. A box surrounds the first two 
conserved cysteines, which are adjacent and conserved in all β -chemokines. Colored boxes indicate the location of the signal peptide and the SCY-domain. 
(c) A Southern blot of S8, S10 and SR1 genomic DNA digested with EcoRI. The upper panel shows the signal from hybridization with a Ccl19 probe, and 
the lower panel shows the signal of the same blot hybridized with a control probe demonstrating relative DNA loading. The average Ccl19 signal intensity 
of each S8 lane is 1.9-fold greater than in SR1 and S10 when normalized to the control probe (p < 0.005 with a two-tailed Student's t-test). (d) A Southern 
blot of genomic DNA digested with BamHI. In this case, the lower panel shows the signal from hybridization with a Ccl19 probe, and the upper panel 
shows the signal of the same blot hybridized with a control probe demonstrating relative DNA loading. The average Ccl19 signal intensity seen in S8 is 2.6-
fold greater than in SR1 and S10 when normalized to the control probe (p < 0.003 with a two-tailed Student's t-test).
10        20        30        40        50          
---------|---------|---------|---------|---------|----------
1 MAPRVTPLLAFSLLVLWTFPAPTLGGANDAEDCCLSVTQRPIPGNIVKAFRYLLNEDGCR CCL19 reference
1 MAPRVTPLLAFSLLVLWTFPAPTLGGANDAEDCCLSVTQRPIPGNIVKAFRYLLNEDGCR CCL19 SR spleen
1 MAPRVTPLLAFSLLVLWTFPAPTLGGANDAEDCCLSVTQRPIPGNIVKAFRYLLNEDGCR CCL19 S8 spleen
1 MAPRVTPLLAFSLLVLWTFPAPTLGGANDAEDCCLSVTQRPIPGNIVKAFRYLLNEDGCR CCL19 SR hippocampus
1 ----------------------------------------------MKAFRYLLNEDGCR CCL19 S8 hippocampus
70        80        90       100
---------|---------|---------|---------|--------
60 VPAVVFTTLRGYQLCAPPDQPWVDRIIRRLKKSSAKNKGNSTRRSPVS CCL19 reference
60 VPAVVFTTLRGYQLCAPPDQPWVDRIIRRLKKSSAKNKGNSTRRSPVS CCL19 SR spleen
60 VPAVVFTTLRGYQLCAPPDQPWVDRIIRRLKKSSAKNKGNSTRRSPVS CCL19 S8 spleen
60 VPAVVFTTLRGYQLCAPPDQPWVDRIIRRLKKSSAKNKGNSTRRSPVS CCL19 SR hippocampus
60 VPAVVFTTLRGYQLCAPPDQPWVDRIIRRLKKSSAKNKGNSTRRSPVS CCL19 S8 hippocampus
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7a). To confirm that the mutation affected the protein, west-
ern blotting was performed. Western analysis on brain
extracts from S8, S10 and SR1 mice using a carboxy-terminal
antibody confirmed the absence of normal FGF1 protein in
the brain of S10 mice (Figure 7b). As fibroblast growth factors
have been linked to specific roles in the central nervous sys-
tem [41,42], it is tempting to speculate that the mutation in
this gene plays a role in the senescence-associated neurode-
generation seen in S10 mice.
Discussion
Animal models for the study of complex diseases that are late-
manifesting are difficult to create. This poses a major chal-
lenge when attempting to study human diseases that occur
d u r i n g  t h e  p r o c e s s  o f  a g i n g .  T h i s  p r o b l e m  i s  e x a g g e r a t e d
when the disease process may emerge not as a discrete phe-
nomenon but rather as a constellation of processes that cas-
cade and ultimately lead to the complex disease. The rare
inbred mouse strains generated by careful breeding and
selection known as the senescence-accelerated prone mice
afforded us the opportunity to study a complex cascade that
ultimately leads to progressive neurological decline during
the aging process. Although these animals are difficult to
maintain and little is known regarding the underlying genet-
ics that predispose these mice to accelerated senescence, their
extraordinary phenotype motivated us to study these mice
using transcriptional profiling and targeted polymorphism
screening to begin to dissect the pathways that lead to the
disease phenotype and to compare these changes with those
that occur during the 'normal' neurological aging process in
two control strains.
Our studies suggest a role for the identified genes and path-
ways in the neuropathological phenotypes seen in S8 and S10
mice and, at a minimum, provide a set of likely candidate
genes and mutations for further study. Importantly, this work
Absence of wild-type FGF1 in S10 cortex Figure 7
Absence of wild-type FGF1 in S10 cortex. (a) Predicted amino-acid sequence of FGF1 protein from SR1 and S10 hippocampus reveals a putative 
truncation of the S10 protein sequence at the carboxy terminus. The reference FGF1 protein sequence is shown at the top. The site of the 15-bp insertion 
is indicated by an arrow and the resulting amino-acid changes and the truncation predicted in S10 FGF1 are highlighted in yellow. The nuclear localization 
signal (NLS), the FGF core domain and the heparin-binding motif are indicated by boxes. (b) A western blot of S8, S10 and SR1 cortices probed with an 
antibody specific for the carboxy terminus of FGF1 is shown. This region is predicted to be deleted in S10 mice. Wild-type mouse FGF1 is 155 amino acids 
and 17.4 kD. As predicted, wild-type FGF1 is detected in the cortices of S8 and SR1, but not S10, consistent with the predicted truncation of the protein 
in that strain of mice.
130        140        150        
----------|----------|----------|-------
120 KNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD fgf1 reference
120 KNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD fgf1 SR Hp
120 ------------------------------------ fgf1 S10 Hp
Heparin binding motif
70         80        90       100       110         
---------|----------|---------|---------|---------|--------
60 LSAESAGEVYIKGTETGQYLAMDTEGLLYGSQTPNEECLFLERLEENHYNTYTSKKHAE fgf1 reference
60 LSAESAGEVYIKGTETGQYLAMDTEGLLYGSQTPNEECLFLERLEENHYNTYTSKKHAE fgf1 SR  Hp
60 LSAESAGEVYIKGTETGQYLAMDTEGLLYGSFLSF------------------------ fgf1 S10 Hp
10        20        30        40        50          
---------|---------|---------|---------|---------|----------
1 MAEGEITTFAALTERFNLPLGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQ fgf1 reference
1 MAEGEITTFAALTERFNLPLGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQ fgf1 SR  Hp
1 MAEGEITTFAALTERFNLPLGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQ fgf1 S10 Hp
NLS FGF core domain
FGF1
S8 S10 SR1
(a)
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demonstrates that it is possible to use large-scale gene expres-
sion profiling to identify genotypic differences between
strains and link them to a phenotype. We sought to test
whether gene expression profiling combined with follow-up
of specific genes could be exploited to identify candidate
pathways involved in aging processes. We found that we
could identify genes likely to be involved in the aging process
in multiple mouse strains, and also apply genomics to the
study of inbred mice to proceed beyond the search for general
patterns of gene expression toward the identification of spe-
cific mutations in the accelerated-aging models.
From genomics to specific genes
The combination of gene-expression profiling and the use of
inbred mouse strains revealed the presence of a block of dif-
ferentially regulated genes on chromosome 4 in S8 mice. Fol-
low-up studies confirmed a duplication event containing at
least one gene in the region, Ccl19. Given the important role
that inflammatory processes could have in CNS aging, both
Ccl19 and the closely linked Ccl27 could play primary roles in
the neurological phenotypes seen in the S8 strain. Our results
suggest that a large-scale duplication event of a region of
chromosome 4 results in increased expression of multiple
genes in the brains of S8 mice.
We have also identified a potentially important mutation in
the growth factor gene Fgf1 in S10 that results in a nonsense
codon in the predicted amino-acid sequence, and western
analysis confirmed that normal FGF1 protein is not detecta-
ble in the brains of these animals. Interestingly, FGF1 has
been shown to protect neurons from excitotoxic stress, and
low FGF1 mRNA levels have been implicated in Alzheimer's
disease [43-46]. The absence of intact FGF1 in the S10 mice
could be critical in the age-related neurodegeneration and
brain atrophy observed in the S10 strain.
The opportunistic polymorphism screening approach we pur-
sued led to multiple candidate genes. It is exciting to postulate
that future availability of more complete sequence and/or
high density SNP information will make possible the combi-
nation of genomic information with full genome expression
profiling to delineate specific mutations and expression dif-
ferences that point to a host of intriguing candidates for com-
plex traits.
General aspects of aging
While the majority of genes found to be differentially
expressed in the hippocampus and retina were specific to one
or two strains, two genes in particular stood out as potentially
'universal' markers for molecular processes involved in aging.
In the hippocampus, C4 was upregulated in old S8, S10, SR1
and B6J mice. C4 was also upregulated in the aging neocortex
and cerebellum of B6J, suggesting that the complement cas-
cade plays a common role in aging in multiple inbred mouse
strains and brain regions [47]. Other components of the com-
plement cascade were also upregulated in the Lee et al. study
[47], including C1q A-chain, C1q B-chain, and C1q C-chain.
Examination of these genes in our data revealed that, while
the changes were not significant enough to meet our most
stringent criteria, the C1q A-chain, C1q B-chain transcripts
were elevated approximately 1.3-fold in aged S8, S10 and SR1
hippocampus (S8 p-value = 0.05 and 0.08 for C1q A- and B-
chains, respectively; S10 p-value = 0.03 and 0.05 for C1q A-
and B-chain, respectively; and SR1 p-value = 0.03 and 0.1 for
C1q A- and B-chains, respectively). Increases in immune-
response genes in the aging brain have been found in several
different mouse strains and there is a growing body of evi-
dence supporting the importance of chronic inflammation in
mammalian aging [47-49]. Intriguingly, such an immune/
inflammatory response may play a particularly important
role in the nervous system, as similar increases were not seen
in gene expression studies of aging muscle or fibroblasts
[50,51]. Other studies in B6J mice also show involvement of
inflammatory pathways in the aging retina ([52] and S.Y.,
unpublished work). One study has also reported increased
levels of immune-related transcripts with age in the liver of
another strain (C3B10RF1), suggesting that there may be
other tissues with age-related immune responses [53].
Importantly, studies of caloric restriction, the only known
method of life-extension in mammals, show that restricting
food intake results in the downregulation of genes involved in
inflammation [47,49].
Another interesting gene identified was the mouse homolog
of  phosphatidylserine decarboxylase (PSDC), a transcript
up-regulated in the aging retina of all strains and the aging
hippocampus of S8, SR1 and B6J. This gene encodes an
enzyme localized to the inner mitochondrial membrane that
is involved in phospholipid biosynthesis. It is possible that
the upregulation of PSDC may provide a mechanism to com-
pensate for oxidative damage to membranes in the CNS [54].
Finally, a recent report examining gene regulation and the
aging human brain identified many genes in the same path-
ways that we have identified here, including genes involved in
stress response, inflammation and vesicular transport [55].
Strain-specific transcriptional response to aging
In addition to the identification of genes and mutations
potentially involved in aging, our results demonstrated some
unexpected findings. Surprisingly, we found that different
inbred strains of mice demonstrated strikingly distinct aging
patterns (Figure 2). Of the many genes differentially
expressed, very few were in common between the three SAM
strains and B6J. More age-related gene expression changes
were found in common between the SAM strains than the
B6J, most likely reflecting the close genetic relationship
between the AKR/J-derived SAM strains, but even within the
SAM mice, there were significant differences between the
strains in the patterns of expression changes. This suggests
that the use of any single inbred mouse strain to study tran-
scriptional events associated with mammalian aging may be
misleading or incomplete and that it is best to use multiplehttp://genomebiology.com/2005/6/6/R48 Genome Biology 2005,     Volume 6, Issue 6, Article R48       Carter et al. R48.13
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strains in order to model general mammalian aging
processes.
The two strains demonstrating accelerated aging, S8 and S10,
shared many differences relative to SR1, including increased
expression levels of stress-response genes such as those for
the heat-shock proteins Hsp70-1 and Hspa5, and for X-box
binding protein 1 (Xbp1). The senescence-prone mice also
demonstrated differential expression of some genes known to
be involved in human diseases: these include transthyretin
(Ttr) and Kcnq2, both of which show decreased levels of
expression in S8 and S10.
Another interesting gene-expression difference between the
strains was the increase in Iap mRNA levels observed in S8
and S10 hippocampus and retina relative to SR1. Iap
sequences are repetitive transposable elements present in
approximately 1,000 copies per mouse genome, and tran-
script levels have been reported to increase with age in the
liver of some strains [56-58]. This increase has been shown to
be associated with demethylation of an Iap promoter, sug-
gesting a failure of repression mechanisms to control retro-
transposon expression in the aging mouse. In the case of S8
and S10, Iap  expression was elevated two- to five-fold in
young mice relative to SR1, and remained elevated through-
out the life span of the mouse.
Interestingly, a global evaluation of transcriptional changes
also revealed a difference in expression trends between S8
and the other strains. In the aging hippocampus, 61% (40/66)
of differentially expressed genes were upregulated in SR1,
69% (29/42) were upregulated in S10 and 82% (14/17) were
upregulated in B6J. These values are consistent with trends
seen in previous studies of other regions of the B6J brain [50].
In contrast, only 46% (18/39) of genes were upregulated with
age in the S8 hippocampus. These same trends were seen in
the aging retina, with S10, SR1 and B6J showing upregulation
of at least 80% of differentially expressed genes (22/24, 15/16
and 8/10, respectively). The aging S8 retina showed only 24%
(5/21) of genes up-regulated. This general difference in age-
related gene expression levels supports a global difference in
transcriptional regulation in S8 neuronal tissues. Therefore,
while the neurological phenotypes of S8 and S10 mice are
somewhat similar, S8 mice may have a very abnormal tran-
scriptional response to the aging process. One hypothesis
suggested by the data is that certain events during aging trig-
ger the upregulation of important genes. This response occurs
in the SR1, S10 and B6J mice, but is abnormal in S8 mice.
Thus, it is possible that S10 mice exhibit an acceleration of
certain normal molecular responses to aging, while S8 mice
exhibit a malfunction of normal transcriptional responses.
Conclusion
Aging is a complex process involving multiple tissues and
events. Many genes and pathways are implicated from our
gene-expression data, with some very interesting candidates
implicated in the pathology of S8 and S10 mice. Elucidation
of the precise roles these candidate genes play remains diffi-
cult, but the simple identification of such candidates provides
the opportunity for hypothesis formation and testing to fur-
ther characterize their involvement in the aging process. Our
studies suggest that careful analysis of multiple strains, mul-
tiple tissues, and the integration of gene expression data gen-
erated from multiple laboratories will be important for
deciphering the molecular biology of the aging process in
mammals. Ultimately, combining the knowledge gained from
whole-genome sequencing of multiple strains with gene-
expression analyses and careful phenotypic comparison is
likely to provide great insight into the aging process.
Materials and methods
Animal handling
All animal procedures were performed according to protocols
approved by The Salk Institute for Biological Studies Animal
Care and Use Committee. C57BL/6J mice were obtained from
Jackson Laboratories and were housed for one week before
dissection. The senescence-accelerated mouse (SAM) strains
were developed at Kyoto University from a colony of AKR/J
mice that were selectively bred based on senescence, life span
and pathologic phenotypes and were generously provided to
our laboratory [18,20,59]. Founder mating pairs of S8/Ta (F-
105), S10//Ta (F-99) and SR1TA (F-99) mice raised under
specific-pathogen-free conditions were obtained from Kyoto
University as approved by the SAM council. Animals were
maintained in a specific-pathogen-free environment under
standard 12-h light-dark cycles (lights on 6:00 AM - 6:00 PM)
with food and water provided ad libitum. Fertility of the mice
was monitored by plug-checks during matings, and fecundity
was determined by recording the number of offspring.
Necropsies were performed on mice that were used for dissec-
tion, euthanized, or found dead. All mice that died of natural
causes were used in the pathology studies. 237 S8 mice, 169
S10 mice, and 189 SR1 mice were used for the life span analy-
sis. Cause of death was determined by necropsy and classified
as 'cancer,' 'infection,' or 'no cancer or infection.'
Single-trial passive avoidance
Behavioral analyses were performed using a single trial in a
two-compartment step-through passive avoidance apparatus
[23]. During acquisition, a 0.5 mA current was applied to a
floor grid for 3 sec upon animal entry into a darkened cham-
ber. Retention was measured 24 h later as time to enter the
dark chamber, up to a maximum of 300 sec. Male and female
mice were tested at two time points (young time point: aver-
age age of 16 weeks; old time point: average age of 81 weeks).
Tissue collection
Mice were sacrificed between 15:00 and 17:00 by cervical dis-
location. Retinal samples were dissected first and frozen on
dry ice. The brain was then removed and the hippocampusR48.14 Genome Biology 2005,     Volume 6, Issue 6, Article R48       Carter et al. http://genomebiology.com/2005/6/6/R48
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rapidly excised, followed by the removal of the spleen from
the body. All samples were rapidly frozen on dry ice and
stored at -80°C. Total RNA was prepared using Trizol Rea-
gent (Invitrogen) according to the manufacturer's recom-
mended protocol [34].
Gene-expression profiling
Gene-expression profiling was performed on 3 month-old
(young), 16 month-old (old) S8, S10 and SR1 mice, and 3
month-old and 21 month-old B6J mice. Two independent
samples for each time point were used in gene-expression
profiling for each strain. Because of greater replicate variabil-
ity, three samples were used for hippocampus of 16-month
SAM mice. A 10.0 µg sample of total RNA was used to gener-
ate labeled cRNA for each sample according to recommended
protocols (Affymetrix). RNA from multiple animals was not
pooled, except in the case of retina, where the retinas of two
mice were combined to generate sufficient total RNA. Hybrid-
izations were performed on MG_U74Av2 Affymetrix Gene-
Chips for 16 h at 50°C at a final cRNA concentration of 0.66
µg/µl. Data were analyzed using the TeraGenomics relational
database [36]. To identify differentially expressed genes
between any two samples, a Wilcoxon signed-rank test
(WSRR) p-value was calculated using the probe-pair differ-
ence values for a given gene between the two samples. A com-
bined set of criteria, WSRR p-value of p ≤  0.01 and increase
fraction ≥  0.7, or p ≤  0.01 and increase fraction ≤  0.3, was used
to detect genes that showed an increase or decrease in expres-
sion level. To detect less robust but still potentially interesting
gene expression changes, a less stringent set of criteria, p ≤
0.0316 and increase fraction ≥  0.8, or p ≤  0.0316 and increase
fraction ≤  0.2, was used to identify genes as showing a 'mar-
ginal' increase or decrease. Additionally, a fold change of 1.5
or greater and a change in signal ≥  30 was also required. The
above analysis was performed on all possible pairwise com-
parisons of the samples used (that is, two independent young
S8 retinal samples and two independent old S8 retinal sam-
ples resulted in four pairwise comparisons). A gene was con-
sidered differentially expressed (for example, old S8 retina vs
young S8 retina) only if it met the above criteria in at least
70% of the pairwise comparisons (3/4 or 4/4 comparisons).
Finally, the transcript had to meet the following criteria
resulting in an absolute call of P (present, indicating the tran-
script reached reliably detectable levels) in at least one sam-
ple: p ≤  0.0316 and positive fraction ≥  0.6, or p ≤  0.1 and
positive fraction ≥  0.75.
For each analysis (old vs young or strain 1 vs strain 2), all pos-
sible pairwise comparisons were generated (that is, four files
resulting from a comparison of two S8 hippocampus samples
to two SR, or six files resulting from a comparison of three old
S10 hippocampus samples to two young S10 hippocampus
samples) and used in the analyses. This analysis methodology
has been described in more detail in previous publications
[34,61].
The data and analysis tools are freely available at [36].
Polymorphism prediction
Candidate genes harboring predicted polymorphisms were
identified using an algorithm developed by our laboratory
(J.A.G., M.A. Zapala, C.B. and D.J.L., unpublished work).
Briefly, the algorithm works as follows: first, for the selected
probe sets, the individual hybridization intensity values are
extracted and the difference between the perfect match and
the mismatch (PM-MM) intensities is calculated for each
probe pair for each sample, excluding probe sets from sam-
ples that do not meet certain pattern quality measures. The
PM-MM values for each of the probe sets for each sample are
globally scaled (by a factor derived from the standard devia-
tion across the multi-probe pattern obtained in each experi-
ment) to compensate for gene-expression differences. Next,
the scaled values for each sample group are averaged, and an
average and a standard deviation are calculated for each
probe pair in a probe set. A threshold, an empirical measure
of significance, was computed for each probe pair (PP) as
follows:
The algorithm was written in structured query language
(SQL) using Queryman, a Teradata specific compiler [61] to
run on the Teradata relational database.
Real-time quantitative RT-PCR
RNA samples from two to three mice for each strain at each
t i m e - p o i n t  w e r e  u s e d  t o  v e r i fy the gene-expression differ-
ences. RNA used for quantitative PCR (Q-PCR) was inde-
pendent from the RNA used in the Affymetrix microarray
experiments. Standard protocols were used for the generation
of cDNA from RNA following elimination of genomic DNA
contamination using DNA-free (Ambion). Oligonucleotide
primers were designed using Applied Biosystems Primer
Express software v. 1.5. ABI's SYBR Green PCR Master Mix
was used for the Q-PCR reactions, which were then run on the
ABI Prism 7700 sequence detection system. All Q-PCR data
analysis was normalized to peptidylprolyl isomerase B (cyclo-
philin) levels as an internal control.
In situ hybridization
Templates for probes were synthesized by PCR, subcloned
into TOPO-2 (Invitrogen), linearized with EcoRV, and tran-
scribed in vitro using digoxigenin (DIG)-labeled uridine tri-
phosphate (Roche Biomedical Systems) according to the
manufacturer's protocols. For hippocampal and cerebellar
tissue preparation, mice were sacrificed by rapid cervical dis-
location, the brains removed and embedded in OCT on dry
ice, and sliced in 10 µm sections using a cryostat. For retinal
tissue preparation, animals were perfused using 4% parafor-
maldehyde. The eyes were then enucleated, fixed in 4% para-
formaldehyde for 24 h and embedded in paraffin and sliced.
Retinal sections were rehydrated and treated with proteinase
|Average scaled difference (PP , sample group ) Average sc a1 − a aled difference (PP , sample group )|
Standard deviation (
a2
P PP , sample group ) Standard deviation (PP , sample grou a1
2
a + p p) 2
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K. Subsequently, both brain and retinal sections were refixed
in 4% paraformaldehyde for 10 min, washed in PBS and
acetylated. Hybridization was performed overnight at 60°C
using a probe concentration of 0.5-1 µg/ml, and detection was
performed with anti-digoxigenin alkaline phosphatase-con-
jugated Fab fragments (Roche Biomedical Systems) followed
by staining with NBT and BCIP (Roche Biomedical Systems).
Images were collected with a Nikon microscope attached to a
charge-coupled device camera and software (Media Cyber-
netics), using electronically acquired composite images.
Polymorphism identification
Total RNA was extracted from hippocampus and spleen using
methods described above and contaminating genomic DNA
was removed using Ambion's DNA-free according to the man-
ufacturer's recommended procedures. Primers for the ampli-
fication of regions containing putative sequence differences
were designed (length = 17-26 bp; Tm = 55-60°C). Whenever
possible, primers were designed to include the complete
Affymetrix target sequence. All sequencing was performed by
the Salk Institute Sequencing Core.
Northern analysis
Total RNA (10.0 µg for each sample) was incubated at 50°C
for 1 h in the presence of glyoxal, and electrophoresed in 1×
DEPC-treated BPTE buffer in a 1% agarose gel. The gel was
blotted onto Hybond-N+ membrane overnight. A fragment of
the Ccl19 mRNA was amplified using RT-PCR from hippoc-
ampus total RNA. Random primed labeling was used to radi-
oactively label the fragment with 32P and hybridization to the
membrane was performed overnight in Church buffer at
65°C. Four washes of 15-20 min were performed to a maximal
stringency of 0.1× SSC, 0.1% SDS at 65°C. Visualization was
performed on a Molecular Dynamics Phosphorimaging
system.
Southern analysis
Genomic DNA (10.0 µg for each sample) was digested at37°C
using BamHI or EcoRI. The digested samples were electro-
phoresed in 1× TAE buffer on a 0.8% agarose gel overnight at
30 V. The gel was then washed in 0.2 M HCl for 30 min.,
rinsed quickly in distilled water twice, placed in denaturing
buffer (1.5 M NaCl, 0.5 M NaOH) for 30 min, neutralization
buffer (1.5 M NaCl, 0.5 M Tris pH 7.5) for 30 min, and 20×
SSC for 2 min. The gel was then blotted onto a Nytran super-
charge filter (Schleicher & Schuell) in 20× SSC overnight and
UV cross-linked. To create the Ccl19 probe, a fragment of the
Ccl19 mRNA was amplified using RT-PCR from SR cortex
total RNA (primers: GCGGGCTCACTGG-GGCACAC,
TGGGAAGGTCCAGAGAACCAG).  Random primed labeling
was used to radioactively label the fragment with 32P and
hybridization to the membrane was performed overnight in
Church buffer at 65°C. Four washes of 15-20 min were per-
formed to a maximal stringency of 0.1× SSC, 0.1% SDS at
55°C. Visualization was performed on a Molecular Dynamics
Phosphorimaging screen. A SacI-EcoRI 795-bp fragment of
Grik1 was subsequently used as a control probe following the
procedures described for Ccl19.
Immunoprecipitation and western blot
Cortices for two mice of each strain were homogenized in NP-
40 lysis Buffer (20 mM Tris-HCl pH 8.0, 137 mM NaCl, 10%
glycerol, 1% Nonidet P-40, 1 mM EDTA, protease inhibitors
(aprotinin + leupeptin), 1 mM phenyl methyl sulfonyl fluoride
(PMSF)) at 4°C. The samples were then centrifuged and the
supernatant was removed and stored. The protein superna-
tant (1 mg) was pre-cleared with Protein-G Sepharose slurry
for 30 min, then removed and incubated with the Protein-G
Sepharose for 2 h with the anti-FGF1 antibody raised against
the carboxy terminus of human FGF1 (Santa Cruz Biotechnol-
ogy, 1/100 concentration). The Protein-G Sepharose beads
were then removed, washed, and the protein was liberated
upon incubation with SDS buffer at 70°C for 10 min. The
supernatant was then run out on a Novex 12% Bis-Tris gel in
MOPS buffer, blotted, and visualized with a secondary horse-
radish peroxidase-conjugate antibody and detected using the
ECL Plus kit (Amersham Biosciences).
Additional data files
The following additional data are available with the online
version of this paper.  Additional data file 1 contains four sec-
tions explaining the animal handling and gene expression
methodologies. Additional data file 5 contains four
correlation plots of replicate samples. Additional data file 2
contains a summary of all mice used for breeding. Additional
data file 3 contains a summary of the correlations between all
replicate samples and the empirically determined estimated
false-positive rates. Additional data file 4 contains a list of the
genes predicted to harbor polymorphisms between the S8,
S10 and SR1 strains.
Additional data file 1 Animal handling and gene expression methodologies.  Animal handling and gene expression methodologies. Click here for file Additional data file 2 A table containing a summary of all mice used for breeding.  A table containing a summary of all mice used for breeding Click here for file Additional data file 3 A table containing a summary of the correlations between all repli- cate samples and the empirically determined estimated false posi- tive rates.  A table containing a summary of the correlations between all repli- cate samples and the empirically determined estimated false posi- tive rates. Click here for file Additional data file 4 A table listing the genes predicted to harbor polymorphisms  between the S8, S10 and SR1 strains.  A table listing the genes predicted to harbor polymorphisms  between the S8, S10 and SR1 strains. Click here for file Additional data file 5 Supplemental Figure 1: Correlation Between Independent Repli- cates.  Correlation plots for independent replicate measurements. Exam- ples shown are representative of the gene expression data quality  obtained throughout the study. The signal for every gene on the  microarray is graphed on a scatter plot for two replicate samples  (that is, samples of the same strain, same tissue and same age but  different animals). The Pearson correlation coefficient (R) is given  for each comparison, ranging from 0.9752 to 0.9958. (A) Correla- tion plot for S8: 609-4HpOld and S8: 609-3HpOld showing the  high degree of correlation between the two independent replicates.  (B) Correlation plot for one of the same samples as in (A) (S8: 609- 3HpOld) and a third replicate sample (S8: 674-2HpOld) showing a  larger variability between replicates. (C) Correlation plot for S10:  704-3+704-4 Retina Old and S10: 15-4+705-2 Retina Old. (D) Cor- relation plot for SR1: 1349-1+1349-2 Retina Young and SR1: 1348- 1+1348-2. Click here for file
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